Tonix Pharmaceuticals Holding (TNXP) Finished Goods (2023 - 2025)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Finished Goods of $2.1 million for Q4 2025, down 58.29% year-over-year from $5.1 million in Q4 2024, and up 21.35% quarter-over-quarter from $1.8 million in Q3 2025.
Tonix Pharmaceuticals Holding (TNXP) Finished Goods (2023 - 2025) Analysis & Trends
Tonix Pharmaceuticals Holding's Finished Goods history runs 3 years deep, the most recent figure standing at $2.1 million for Q4 2025.
- In Q4 2025, Finished Goods fell 58.29% year-over-year to $2.1 million; the TTM figure through Dec 2025 stood at $2.1 million (down 58.29% YoY), while the FY2025 annual figure was $2.1 million, down 58.29% from the prior year.
- Finished Goods for Q4 2025 stood at $2.1 million, up from $1.8 million in the prior quarter.
- The five-year high for Finished Goods was $7.5 million in Q4 2023, with the low at $1.8 million in Q3 2025.
- The 3-year median for Finished Goods is $2.6 million (2024), against an average of $3.8 million.
- The sharpest annual moves came in 2024 and 2025: Finished Goods tumbled 31.58% in 2024, then sank 58.29% in 2025.
- Tonix Pharmaceuticals Holding's Finished Goods stood at $7.5 million in 2023, then plunged by 31.58% to $5.1 million in 2024, then tumbled by 58.29% to $2.1 million in 2025.
- Business Quant data shows TNXP's Finished Goods at $2.1 million in Q4 2025, $1.8 million in Q3 2025, and $2.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.14 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 2.37 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Dec 31, 2024 | 5.12 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Dec 31, 2023 | 7.49 Mn |